Journal Article10.23736/S1825-859X.19.00004-5
Biopsia liquida: una review
Fabio Del Ben,Michela Bulfoni,Matteo Turetta,Giulia Brisotto,Agostino Steffan,Francesco Curcio +5 more
- 01 May 2019
- Vol. 15, Iss: 1
About: The article was published on 01 May 2019.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy.
Melissa L. Sokolosky,Kristin Stadelman,William H. Chappell,Stephen L. Abrams,Alberto M. Martelli,Franca Stivala,Massimo Libra,Ferdinando Nicoletti,Lyudmyla Drobot,Richard A. Franklin,Linda S. Steelman,James A. McCubrey +11 more
TL;DR: Rapamycin lowered the IC50s for doxorubicin, etoposide and 4HT in the cells which expressed ΔAkt-1(CA), demonstrating a potential improved method for treating certain breast cancers which have deregulated PI3K/PTEN/Akt/mTOR signaling.
High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients
Yin Tang,Zhuo Wang,Ziming Li,Jungwoo Kim,Yuliang Deng,Yan Li,James R. Heath,James R. Heath,Wei Wei,Wei Wei,Lu Shun,Qihui Shi +11 more
TL;DR: A highly sensitive approach for rapid detection of metabolically active tumor cells in MPE via exploiting the altered glucose metabolism of tumor cells relative to benign cells is described, enabling sensitive diagnosis of malignant pleural effusion in the clinic that is associated with metastatic malignancies.
75
COLD-PCR Enrichment of Rare Cancer Mutations prior to Targeted Amplicon Resequencing
TL;DR: It is anticipated that COLD-PCR combined with NGS will elucidate the role of mutations in tumor progression, enabling NGS-based analysis of diverse clinical specimens within clinical practice.
75
Circulating Tumor Cell Isolation and Analysis.
TL;DR: Recently microfluidic devices represent a promising platform for isolating cancer cells with high efficiency in processing complex cellular fluids, with simplicity, sensitivity, and throughput.
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
Ioanna Balgkouranidou,Maria Chimonidou,Georgia Milaki,E G Tsarouxa,Stylianos Kakolyris,Danny R. Welch,V. Georgoulias,Evi Lianidou +7 more
TL;DR: Evaluating the prognostic significance of BRMS1 promoter methylation in cell-free DNA circulating in plasma of non-small cell lung cancer (NSCLC) patients found it provides important prognostic information and merits to be further evaluated as a circulating tumour biomarker.